Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of a meeting of the NIH Clinical Center Research Hospital Board.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
The portion of the meeting devoted to the identification and evaluation of specific candidates for consideration for leadership positions in the Clinical Center will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B) and 552b(c)(6), Title 5 U.S.C., as amended. Premature disclosure of potential candidates and their qualifications, as well as the discussions by the committee, could significantly frustrate NIH's ability to recruit these individuals and the consideration of personnel qualifications, performance, and the competence of individuals as candidates would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: April 28, 2017.
Open: 8:30 a.m. to 3:20 p.m.
Agenda: Clinical Center Tour (8:30-9:45) Welcome and Board Chair's Overview; NIH Director's Remarks, NIH CC CEO: First 100 Days; CCRHB-Clinical Center Governing Board Joint Session; Delayed Reporting Root Cause Analysis; Clinical Trials Support Realignment.
Place: Conference Room 6C6 (except for Clinical Center Tour), Building 31, National Institutes of Health, Bethesda, MD 20892.
Closed: 3:20 p.m. to 5:00 p.m.
Agenda: Identification of Candidates for Leadership Roles.
Place: Conference Room 6C6, Building 31, National Institutes of Health, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, MD 20892, 301-496-4272, email@example.com.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.
Dated: April 7, 2017.
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07427 Filed 4-12-17; 8:45 am]
BILLING CODE 4140-01-P